nodes	percent_of_prediction	percent_of_DWPC	metapath
Doxazosin—Semen abnormal—Spironolactone—dilated cardiomyopathy	0.105	0.2	CcSEcCtD
Doxazosin—Semen analysis abnormal—Spironolactone—dilated cardiomyopathy	0.105	0.2	CcSEcCtD
Doxazosin—ABCB1—Lisinopril—dilated cardiomyopathy	0.102	0.532	CbGbCtD
Doxazosin—ABCB1—Spironolactone—dilated cardiomyopathy	0.0898	0.468	CbGbCtD
Doxazosin—KCNH2—purkinje fiber—dilated cardiomyopathy	0.0885	0.576	CbGeAlD
Doxazosin—KCNH2—endocardium—dilated cardiomyopathy	0.0456	0.297	CbGeAlD
Doxazosin—Tendon disorder—Lisinopril—dilated cardiomyopathy	0.00784	0.015	CcSEcCtD
Doxazosin—Rash erythematous—Spironolactone—dilated cardiomyopathy	0.00655	0.0125	CcSEcCtD
Doxazosin—Breast pain—Spironolactone—dilated cardiomyopathy	0.00575	0.011	CcSEcCtD
Doxazosin—Cerebration impaired—Furosemide—dilated cardiomyopathy	0.00464	0.00887	CcSEcCtD
Doxazosin—Cramps of lower extremities—Spironolactone—dilated cardiomyopathy	0.00461	0.00881	CcSEcCtD
Doxazosin—Gynaecomastia—Spironolactone—dilated cardiomyopathy	0.00449	0.00858	CcSEcCtD
Doxazosin—Renal pain—Lisinopril—dilated cardiomyopathy	0.00389	0.00744	CcSEcCtD
Doxazosin—KCNH2—cardiac ventricle—dilated cardiomyopathy	0.00384	0.025	CbGeAlD
Doxazosin—Apathy—Furosemide—dilated cardiomyopathy	0.00382	0.0073	CcSEcCtD
Doxazosin—Flat affect—Furosemide—dilated cardiomyopathy	0.00378	0.00724	CcSEcCtD
Doxazosin—KCNH2—myocardium—dilated cardiomyopathy	0.00361	0.0235	CbGeAlD
Doxazosin—Cholestasis—Furosemide—dilated cardiomyopathy	0.00359	0.00687	CcSEcCtD
Doxazosin—Ataxia—Spironolactone—dilated cardiomyopathy	0.00342	0.00654	CcSEcCtD
Doxazosin—Nephrolithiasis—Furosemide—dilated cardiomyopathy	0.00339	0.00649	CcSEcCtD
Doxazosin—Cramp muscle—Spironolactone—dilated cardiomyopathy	0.00328	0.00627	CcSEcCtD
Doxazosin—Psoriasis—Lisinopril—dilated cardiomyopathy	0.00326	0.00623	CcSEcCtD
Doxazosin—Disturbance in attention—Furosemide—dilated cardiomyopathy	0.00315	0.00602	CcSEcCtD
Doxazosin—Hyperuricaemia—Furosemide—dilated cardiomyopathy	0.00294	0.00562	CcSEcCtD
Doxazosin—Gout—Furosemide—dilated cardiomyopathy	0.00292	0.00559	CcSEcCtD
Doxazosin—Erectile dysfunction—Spironolactone—dilated cardiomyopathy	0.0029	0.00554	CcSEcCtD
Doxazosin—Influenza-like symptoms—Lisinopril—dilated cardiomyopathy	0.00287	0.00548	CcSEcCtD
Doxazosin—Drowsiness—Spironolactone—dilated cardiomyopathy	0.0028	0.00536	CcSEcCtD
Doxazosin—Blood uric acid increased—Furosemide—dilated cardiomyopathy	0.00278	0.00531	CcSEcCtD
Doxazosin—Herpes zoster—Lisinopril—dilated cardiomyopathy	0.00272	0.0052	CcSEcCtD
Doxazosin—Otitis media—Lisinopril—dilated cardiomyopathy	0.00263	0.00503	CcSEcCtD
Doxazosin—ADRA1A—heart—dilated cardiomyopathy	0.00261	0.017	CbGeAlD
Doxazosin—KCNH2—heart—dilated cardiomyopathy	0.00252	0.0164	CbGeAlD
Doxazosin—Cramps of lower extremities—Furosemide—dilated cardiomyopathy	0.00251	0.00479	CcSEcCtD
Doxazosin—Urine output increased—Furosemide—dilated cardiomyopathy	0.00247	0.00472	CcSEcCtD
Doxazosin—Bladder pain—Furosemide—dilated cardiomyopathy	0.00247	0.00472	CcSEcCtD
Doxazosin—Mental disability—Furosemide—dilated cardiomyopathy	0.00237	0.00453	CcSEcCtD
Doxazosin—Breast pain—Lisinopril—dilated cardiomyopathy	0.00235	0.00449	CcSEcCtD
Doxazosin—Viral infection—Lisinopril—dilated cardiomyopathy	0.00227	0.00433	CcSEcCtD
Doxazosin—Polyuria—Furosemide—dilated cardiomyopathy	0.00226	0.00431	CcSEcCtD
Doxazosin—Alopecia—Spironolactone—dilated cardiomyopathy	0.00222	0.00425	CcSEcCtD
Doxazosin—Oliguria—Lisinopril—dilated cardiomyopathy	0.00222	0.00425	CcSEcCtD
Doxazosin—Vascular purpura—Furosemide—dilated cardiomyopathy	0.00221	0.00423	CcSEcCtD
Doxazosin—Deafness—Furosemide—dilated cardiomyopathy	0.00221	0.00423	CcSEcCtD
Doxazosin—Gout—Lisinopril—dilated cardiomyopathy	0.00219	0.00419	CcSEcCtD
Doxazosin—KCNH2—cardiac atrium—dilated cardiomyopathy	0.00216	0.014	CbGeAlD
Doxazosin—Muscle spasms—Spironolactone—dilated cardiomyopathy	0.00211	0.00403	CcSEcCtD
Doxazosin—Thirst—Furosemide—dilated cardiomyopathy	0.00208	0.00398	CcSEcCtD
Doxazosin—Purpura—Furosemide—dilated cardiomyopathy	0.00205	0.00393	CcSEcCtD
Doxazosin—Ill-defined disorder—Spironolactone—dilated cardiomyopathy	0.00203	0.00389	CcSEcCtD
Doxazosin—Cystitis noninfective—Lisinopril—dilated cardiomyopathy	0.002	0.00382	CcSEcCtD
Doxazosin—Influenza like illness—Lisinopril—dilated cardiomyopathy	0.00199	0.0038	CcSEcCtD
Doxazosin—ADRA2A—heart—dilated cardiomyopathy	0.00198	0.0129	CbGeAlD
Doxazosin—Malaise—Spironolactone—dilated cardiomyopathy	0.00198	0.00378	CcSEcCtD
Doxazosin—Cystitis—Lisinopril—dilated cardiomyopathy	0.00198	0.00378	CcSEcCtD
Doxazosin—Leukopenia—Spironolactone—dilated cardiomyopathy	0.00196	0.00375	CcSEcCtD
Doxazosin—Photophobia—Lisinopril—dilated cardiomyopathy	0.00192	0.00367	CcSEcCtD
Doxazosin—Urinary retention—Furosemide—dilated cardiomyopathy	0.00188	0.0036	CcSEcCtD
Doxazosin—Bladder pain—Lisinopril—dilated cardiomyopathy	0.00185	0.00354	CcSEcCtD
Doxazosin—Discomfort—Spironolactone—dilated cardiomyopathy	0.00184	0.00352	CcSEcCtD
Doxazosin—Dehydration—Furosemide—dilated cardiomyopathy	0.00184	0.00352	CcSEcCtD
Doxazosin—Orthostatic hypotension—Furosemide—dilated cardiomyopathy	0.00181	0.00346	CcSEcCtD
Doxazosin—Confusional state—Spironolactone—dilated cardiomyopathy	0.0018	0.00345	CcSEcCtD
Doxazosin—Hypokalaemia—Furosemide—dilated cardiomyopathy	0.0018	0.00345	CcSEcCtD
Doxazosin—Hypertonia—Lisinopril—dilated cardiomyopathy	0.00179	0.00343	CcSEcCtD
Doxazosin—Cramp muscle—Furosemide—dilated cardiomyopathy	0.00178	0.00341	CcSEcCtD
Doxazosin—Thrombocytopenia—Spironolactone—dilated cardiomyopathy	0.00175	0.00335	CcSEcCtD
Doxazosin—Muscular weakness—Furosemide—dilated cardiomyopathy	0.00175	0.00334	CcSEcCtD
Doxazosin—Abdominal distension—Furosemide—dilated cardiomyopathy	0.00172	0.00329	CcSEcCtD
Doxazosin—ADRA2A—cardiac atrium—dilated cardiomyopathy	0.0017	0.011	CbGeAlD
Doxazosin—Gastroenteritis—Lisinopril—dilated cardiomyopathy	0.00168	0.0032	CcSEcCtD
Doxazosin—Eczema—Lisinopril—dilated cardiomyopathy	0.00165	0.00316	CcSEcCtD
Doxazosin—Libido decreased—Lisinopril—dilated cardiomyopathy	0.0016	0.00306	CcSEcCtD
Doxazosin—Somnolence—Spironolactone—dilated cardiomyopathy	0.00159	0.00304	CcSEcCtD
Doxazosin—Pollakiuria—Furosemide—dilated cardiomyopathy	0.00158	0.00302	CcSEcCtD
Doxazosin—Atrial fibrillation—Lisinopril—dilated cardiomyopathy	0.00157	0.003	CcSEcCtD
Doxazosin—Photosensitivity reaction—Furosemide—dilated cardiomyopathy	0.00156	0.00299	CcSEcCtD
Doxazosin—Hyperglycaemia—Furosemide—dilated cardiomyopathy	0.00154	0.00295	CcSEcCtD
Doxazosin—Arthritis—Lisinopril—dilated cardiomyopathy	0.00153	0.00292	CcSEcCtD
Doxazosin—Drowsiness—Furosemide—dilated cardiomyopathy	0.00153	0.00292	CcSEcCtD
Doxazosin—Cerebrovascular accident—Lisinopril—dilated cardiomyopathy	0.00152	0.0029	CcSEcCtD
Doxazosin—Diplopia—Lisinopril—dilated cardiomyopathy	0.00149	0.00284	CcSEcCtD
Doxazosin—Feeling abnormal—Spironolactone—dilated cardiomyopathy	0.00147	0.00282	CcSEcCtD
Doxazosin—Disturbance in sexual arousal—Lisinopril—dilated cardiomyopathy	0.00147	0.00282	CcSEcCtD
Doxazosin—Sweating—Furosemide—dilated cardiomyopathy	0.00146	0.0028	CcSEcCtD
Doxazosin—Face oedema—Lisinopril—dilated cardiomyopathy	0.00143	0.00274	CcSEcCtD
Doxazosin—Urticaria—Spironolactone—dilated cardiomyopathy	0.00142	0.00272	CcSEcCtD
Doxazosin—Body temperature increased—Spironolactone—dilated cardiomyopathy	0.00141	0.0027	CcSEcCtD
Doxazosin—Ataxia—Lisinopril—dilated cardiomyopathy	0.0014	0.00267	CcSEcCtD
Doxazosin—Dehydration—Lisinopril—dilated cardiomyopathy	0.00138	0.00264	CcSEcCtD
Doxazosin—Orthostatic hypotension—Lisinopril—dilated cardiomyopathy	0.00136	0.00259	CcSEcCtD
Doxazosin—Cramp muscle—Lisinopril—dilated cardiomyopathy	0.00134	0.00256	CcSEcCtD
Doxazosin—Visual impairment—Furosemide—dilated cardiomyopathy	0.00132	0.00252	CcSEcCtD
Doxazosin—Hypersensitivity—Spironolactone—dilated cardiomyopathy	0.00132	0.00252	CcSEcCtD
Doxazosin—Eye disorder—Furosemide—dilated cardiomyopathy	0.00128	0.00245	CcSEcCtD
Doxazosin—Tinnitus—Furosemide—dilated cardiomyopathy	0.00128	0.00244	CcSEcCtD
Doxazosin—Pruritus—Spironolactone—dilated cardiomyopathy	0.00127	0.00242	CcSEcCtD
Doxazosin—Bronchospasm—Lisinopril—dilated cardiomyopathy	0.00126	0.00241	CcSEcCtD
Doxazosin—Sweating increased—Lisinopril—dilated cardiomyopathy	0.00125	0.00239	CcSEcCtD
Doxazosin—Angina pectoris—Lisinopril—dilated cardiomyopathy	0.00125	0.00239	CcSEcCtD
Doxazosin—Bronchitis—Lisinopril—dilated cardiomyopathy	0.00123	0.00236	CcSEcCtD
Doxazosin—Diarrhoea—Spironolactone—dilated cardiomyopathy	0.00122	0.00234	CcSEcCtD
Doxazosin—Arrhythmia—Furosemide—dilated cardiomyopathy	0.00122	0.00234	CcSEcCtD
Doxazosin—Dysuria—Lisinopril—dilated cardiomyopathy	0.0012	0.0023	CcSEcCtD
Doxazosin—Neutropenia—Lisinopril—dilated cardiomyopathy	0.0012	0.0023	CcSEcCtD
Doxazosin—Upper respiratory tract infection—Lisinopril—dilated cardiomyopathy	0.00119	0.00228	CcSEcCtD
Doxazosin—Malnutrition—Furosemide—dilated cardiomyopathy	0.00119	0.00228	CcSEcCtD
Doxazosin—Dizziness—Spironolactone—dilated cardiomyopathy	0.00118	0.00226	CcSEcCtD
Doxazosin—Erectile dysfunction—Lisinopril—dilated cardiomyopathy	0.00118	0.00226	CcSEcCtD
Doxazosin—Flatulence—Furosemide—dilated cardiomyopathy	0.00118	0.00225	CcSEcCtD
Doxazosin—Photosensitivity reaction—Lisinopril—dilated cardiomyopathy	0.00117	0.00224	CcSEcCtD
Doxazosin—Weight increased—Lisinopril—dilated cardiomyopathy	0.00117	0.00223	CcSEcCtD
Doxazosin—Dysgeusia—Furosemide—dilated cardiomyopathy	0.00117	0.00223	CcSEcCtD
Doxazosin—Weight decreased—Lisinopril—dilated cardiomyopathy	0.00116	0.00222	CcSEcCtD
Doxazosin—Hyperglycaemia—Lisinopril—dilated cardiomyopathy	0.00116	0.00221	CcSEcCtD
Doxazosin—Pneumonia—Lisinopril—dilated cardiomyopathy	0.00115	0.0022	CcSEcCtD
Doxazosin—Muscle spasms—Furosemide—dilated cardiomyopathy	0.00115	0.00219	CcSEcCtD
Doxazosin—Depression—Lisinopril—dilated cardiomyopathy	0.00114	0.00218	CcSEcCtD
Doxazosin—Vomiting—Spironolactone—dilated cardiomyopathy	0.00114	0.00217	CcSEcCtD
Doxazosin—Acute coronary syndrome—Lisinopril—dilated cardiomyopathy	0.00113	0.00216	CcSEcCtD
Doxazosin—Rash—Spironolactone—dilated cardiomyopathy	0.00113	0.00216	CcSEcCtD
Doxazosin—Dermatitis—Spironolactone—dilated cardiomyopathy	0.00113	0.00215	CcSEcCtD
Doxazosin—Vision blurred—Furosemide—dilated cardiomyopathy	0.00112	0.00215	CcSEcCtD
Doxazosin—Myocardial infarction—Lisinopril—dilated cardiomyopathy	0.00112	0.00215	CcSEcCtD
Doxazosin—Headache—Spironolactone—dilated cardiomyopathy	0.00112	0.00214	CcSEcCtD
Doxazosin—Jaundice—Lisinopril—dilated cardiomyopathy	0.00112	0.00213	CcSEcCtD
Doxazosin—Urinary tract infection—Lisinopril—dilated cardiomyopathy	0.00111	0.00213	CcSEcCtD
Doxazosin—ABCB1—heart—dilated cardiomyopathy	0.00111	0.0072	CbGeAlD
Doxazosin—Sweating—Lisinopril—dilated cardiomyopathy	0.0011	0.0021	CcSEcCtD
Doxazosin—Agitation—Furosemide—dilated cardiomyopathy	0.0011	0.0021	CcSEcCtD
Doxazosin—Haematuria—Lisinopril—dilated cardiomyopathy	0.00109	0.00209	CcSEcCtD
Doxazosin—Epistaxis—Lisinopril—dilated cardiomyopathy	0.00108	0.00206	CcSEcCtD
Doxazosin—Sinusitis—Lisinopril—dilated cardiomyopathy	0.00107	0.00205	CcSEcCtD
Doxazosin—Vertigo—Furosemide—dilated cardiomyopathy	0.00107	0.00205	CcSEcCtD
Doxazosin—Leukopenia—Furosemide—dilated cardiomyopathy	0.00107	0.00204	CcSEcCtD
Doxazosin—Nausea—Spironolactone—dilated cardiomyopathy	0.00106	0.00203	CcSEcCtD
Doxazosin—Bradycardia—Lisinopril—dilated cardiomyopathy	0.00105	0.002	CcSEcCtD
Doxazosin—Rhinitis—Lisinopril—dilated cardiomyopathy	0.00103	0.00197	CcSEcCtD
Doxazosin—Hepatitis—Lisinopril—dilated cardiomyopathy	0.00103	0.00197	CcSEcCtD
Doxazosin—Pharyngitis—Lisinopril—dilated cardiomyopathy	0.00102	0.00195	CcSEcCtD
Doxazosin—Dry mouth—Furosemide—dilated cardiomyopathy	0.000993	0.0019	CcSEcCtD
Doxazosin—Confusional state—Furosemide—dilated cardiomyopathy	0.000981	0.00188	CcSEcCtD
Doxazosin—Tinnitus—Lisinopril—dilated cardiomyopathy	0.000958	0.00183	CcSEcCtD
Doxazosin—Shock—Furosemide—dilated cardiomyopathy	0.000957	0.00183	CcSEcCtD
Doxazosin—Flushing—Lisinopril—dilated cardiomyopathy	0.000954	0.00182	CcSEcCtD
Doxazosin—Thrombocytopenia—Furosemide—dilated cardiomyopathy	0.000953	0.00182	CcSEcCtD
Doxazosin—Skin disorder—Furosemide—dilated cardiomyopathy	0.000945	0.00181	CcSEcCtD
Doxazosin—Hyperhidrosis—Furosemide—dilated cardiomyopathy	0.000941	0.0018	CcSEcCtD
Doxazosin—Anorexia—Furosemide—dilated cardiomyopathy	0.000928	0.00177	CcSEcCtD
Doxazosin—Chills—Lisinopril—dilated cardiomyopathy	0.000922	0.00176	CcSEcCtD
Doxazosin—Arrhythmia—Lisinopril—dilated cardiomyopathy	0.000918	0.00176	CcSEcCtD
Doxazosin—Hypotension—Furosemide—dilated cardiomyopathy	0.000909	0.00174	CcSEcCtD
Doxazosin—Alopecia—Lisinopril—dilated cardiomyopathy	0.000908	0.00174	CcSEcCtD
Doxazosin—Mental disorder—Lisinopril—dilated cardiomyopathy	0.0009	0.00172	CcSEcCtD
Doxazosin—Malnutrition—Lisinopril—dilated cardiomyopathy	0.000895	0.00171	CcSEcCtD
Doxazosin—Flatulence—Lisinopril—dilated cardiomyopathy	0.000882	0.00169	CcSEcCtD
Doxazosin—Tension—Lisinopril—dilated cardiomyopathy	0.000878	0.00168	CcSEcCtD
Doxazosin—Dysgeusia—Lisinopril—dilated cardiomyopathy	0.000876	0.00168	CcSEcCtD
Doxazosin—Paraesthesia—Furosemide—dilated cardiomyopathy	0.000874	0.00167	CcSEcCtD
Doxazosin—Nervousness—Lisinopril—dilated cardiomyopathy	0.000869	0.00166	CcSEcCtD
Doxazosin—Back pain—Lisinopril—dilated cardiomyopathy	0.000865	0.00165	CcSEcCtD
Doxazosin—Somnolence—Furosemide—dilated cardiomyopathy	0.000865	0.00165	CcSEcCtD
Doxazosin—Muscle spasms—Lisinopril—dilated cardiomyopathy	0.00086	0.00164	CcSEcCtD
Doxazosin—Decreased appetite—Furosemide—dilated cardiomyopathy	0.000846	0.00162	CcSEcCtD
Doxazosin—Vision blurred—Lisinopril—dilated cardiomyopathy	0.000843	0.00161	CcSEcCtD
Doxazosin—Fatigue—Furosemide—dilated cardiomyopathy	0.000839	0.0016	CcSEcCtD
Doxazosin—Tremor—Lisinopril—dilated cardiomyopathy	0.000838	0.0016	CcSEcCtD
Doxazosin—Constipation—Furosemide—dilated cardiomyopathy	0.000832	0.00159	CcSEcCtD
Doxazosin—Pain—Furosemide—dilated cardiomyopathy	0.000832	0.00159	CcSEcCtD
Doxazosin—Ill-defined disorder—Lisinopril—dilated cardiomyopathy	0.00083	0.00159	CcSEcCtD
Doxazosin—Malaise—Lisinopril—dilated cardiomyopathy	0.000807	0.00154	CcSEcCtD
Doxazosin—Vertigo—Lisinopril—dilated cardiomyopathy	0.000804	0.00154	CcSEcCtD
Doxazosin—Syncope—Lisinopril—dilated cardiomyopathy	0.000802	0.00153	CcSEcCtD
Doxazosin—Feeling abnormal—Furosemide—dilated cardiomyopathy	0.000802	0.00153	CcSEcCtD
Doxazosin—Leukopenia—Lisinopril—dilated cardiomyopathy	0.000801	0.00153	CcSEcCtD
Doxazosin—Gastrointestinal pain—Furosemide—dilated cardiomyopathy	0.000796	0.00152	CcSEcCtD
Doxazosin—Palpitations—Lisinopril—dilated cardiomyopathy	0.000791	0.00151	CcSEcCtD
Doxazosin—Loss of consciousness—Lisinopril—dilated cardiomyopathy	0.000786	0.0015	CcSEcCtD
Doxazosin—Cough—Lisinopril—dilated cardiomyopathy	0.000781	0.00149	CcSEcCtD
Doxazosin—Urticaria—Furosemide—dilated cardiomyopathy	0.000773	0.00148	CcSEcCtD
Doxazosin—Abdominal pain—Furosemide—dilated cardiomyopathy	0.000769	0.00147	CcSEcCtD
Doxazosin—Body temperature increased—Furosemide—dilated cardiomyopathy	0.000769	0.00147	CcSEcCtD
Doxazosin—Chest pain—Lisinopril—dilated cardiomyopathy	0.000762	0.00146	CcSEcCtD
Doxazosin—Myalgia—Lisinopril—dilated cardiomyopathy	0.000762	0.00146	CcSEcCtD
Doxazosin—Arthralgia—Lisinopril—dilated cardiomyopathy	0.000762	0.00146	CcSEcCtD
Doxazosin—Anxiety—Lisinopril—dilated cardiomyopathy	0.000759	0.00145	CcSEcCtD
Doxazosin—Discomfort—Lisinopril—dilated cardiomyopathy	0.000753	0.00144	CcSEcCtD
Doxazosin—Dry mouth—Lisinopril—dilated cardiomyopathy	0.000745	0.00142	CcSEcCtD
Doxazosin—Confusional state—Lisinopril—dilated cardiomyopathy	0.000736	0.00141	CcSEcCtD
Doxazosin—Oedema—Lisinopril—dilated cardiomyopathy	0.00073	0.0014	CcSEcCtD
Doxazosin—Infection—Lisinopril—dilated cardiomyopathy	0.000725	0.00139	CcSEcCtD
Doxazosin—Shock—Lisinopril—dilated cardiomyopathy	0.000718	0.00137	CcSEcCtD
Doxazosin—Hypersensitivity—Furosemide—dilated cardiomyopathy	0.000717	0.00137	CcSEcCtD
Doxazosin—Thrombocytopenia—Lisinopril—dilated cardiomyopathy	0.000715	0.00137	CcSEcCtD
Doxazosin—Tachycardia—Lisinopril—dilated cardiomyopathy	0.000713	0.00136	CcSEcCtD
Doxazosin—Skin disorder—Lisinopril—dilated cardiomyopathy	0.000709	0.00136	CcSEcCtD
Doxazosin—Hyperhidrosis—Lisinopril—dilated cardiomyopathy	0.000706	0.00135	CcSEcCtD
Doxazosin—Asthenia—Furosemide—dilated cardiomyopathy	0.000698	0.00134	CcSEcCtD
Doxazosin—Anorexia—Lisinopril—dilated cardiomyopathy	0.000696	0.00133	CcSEcCtD
Doxazosin—Pruritus—Furosemide—dilated cardiomyopathy	0.000689	0.00132	CcSEcCtD
Doxazosin—Hypotension—Lisinopril—dilated cardiomyopathy	0.000682	0.0013	CcSEcCtD
Doxazosin—Diarrhoea—Furosemide—dilated cardiomyopathy	0.000666	0.00127	CcSEcCtD
Doxazosin—Musculoskeletal discomfort—Lisinopril—dilated cardiomyopathy	0.000665	0.00127	CcSEcCtD
Doxazosin—Insomnia—Lisinopril—dilated cardiomyopathy	0.00066	0.00126	CcSEcCtD
Doxazosin—Paraesthesia—Lisinopril—dilated cardiomyopathy	0.000656	0.00125	CcSEcCtD
Doxazosin—Dyspnoea—Lisinopril—dilated cardiomyopathy	0.000651	0.00124	CcSEcCtD
Doxazosin—Somnolence—Lisinopril—dilated cardiomyopathy	0.000649	0.00124	CcSEcCtD
Doxazosin—Dizziness—Furosemide—dilated cardiomyopathy	0.000644	0.00123	CcSEcCtD
Doxazosin—Dyspepsia—Lisinopril—dilated cardiomyopathy	0.000643	0.00123	CcSEcCtD
Doxazosin—Decreased appetite—Lisinopril—dilated cardiomyopathy	0.000635	0.00121	CcSEcCtD
Doxazosin—Fatigue—Lisinopril—dilated cardiomyopathy	0.00063	0.0012	CcSEcCtD
Doxazosin—Pain—Lisinopril—dilated cardiomyopathy	0.000624	0.00119	CcSEcCtD
Doxazosin—Constipation—Lisinopril—dilated cardiomyopathy	0.000624	0.00119	CcSEcCtD
Doxazosin—Vomiting—Furosemide—dilated cardiomyopathy	0.000619	0.00118	CcSEcCtD
Doxazosin—Rash—Furosemide—dilated cardiomyopathy	0.000614	0.00117	CcSEcCtD
Doxazosin—Dermatitis—Furosemide—dilated cardiomyopathy	0.000613	0.00117	CcSEcCtD
Doxazosin—Headache—Furosemide—dilated cardiomyopathy	0.00061	0.00117	CcSEcCtD
Doxazosin—Feeling abnormal—Lisinopril—dilated cardiomyopathy	0.000602	0.00115	CcSEcCtD
Doxazosin—Gastrointestinal pain—Lisinopril—dilated cardiomyopathy	0.000597	0.00114	CcSEcCtD
Doxazosin—Urticaria—Lisinopril—dilated cardiomyopathy	0.00058	0.00111	CcSEcCtD
Doxazosin—Nausea—Furosemide—dilated cardiomyopathy	0.000578	0.00111	CcSEcCtD
Doxazosin—Body temperature increased—Lisinopril—dilated cardiomyopathy	0.000577	0.0011	CcSEcCtD
Doxazosin—Abdominal pain—Lisinopril—dilated cardiomyopathy	0.000577	0.0011	CcSEcCtD
Doxazosin—Hypersensitivity—Lisinopril—dilated cardiomyopathy	0.000538	0.00103	CcSEcCtD
Doxazosin—Asthenia—Lisinopril—dilated cardiomyopathy	0.000524	0.001	CcSEcCtD
Doxazosin—Pruritus—Lisinopril—dilated cardiomyopathy	0.000517	0.000988	CcSEcCtD
Doxazosin—Diarrhoea—Lisinopril—dilated cardiomyopathy	0.0005	0.000955	CcSEcCtD
Doxazosin—Dizziness—Lisinopril—dilated cardiomyopathy	0.000483	0.000923	CcSEcCtD
Doxazosin—Vomiting—Lisinopril—dilated cardiomyopathy	0.000464	0.000888	CcSEcCtD
Doxazosin—Rash—Lisinopril—dilated cardiomyopathy	0.00046	0.00088	CcSEcCtD
Doxazosin—Dermatitis—Lisinopril—dilated cardiomyopathy	0.00046	0.000879	CcSEcCtD
Doxazosin—Headache—Lisinopril—dilated cardiomyopathy	0.000457	0.000875	CcSEcCtD
Doxazosin—Nausea—Lisinopril—dilated cardiomyopathy	0.000434	0.000829	CcSEcCtD
Doxazosin—ABCB1—Allograft Rejection—FAS—dilated cardiomyopathy	0.000241	0.00183	CbGpPWpGaD
Doxazosin—ADRA1D—G alpha (q) signalling events—AGT—dilated cardiomyopathy	0.000239	0.00182	CbGpPWpGaD
Doxazosin—CYP2C19—Metabolism of lipids and lipoproteins—ANKRD1—dilated cardiomyopathy	0.000235	0.00179	CbGpPWpGaD
Doxazosin—ADRA2A—G alpha (i) signalling events—CXCR3—dilated cardiomyopathy	0.000234	0.00178	CbGpPWpGaD
Doxazosin—ADRA1A—GPCRs, Class A Rhodopsin-like—CXCR3—dilated cardiomyopathy	0.000234	0.00178	CbGpPWpGaD
Doxazosin—ADRA2A—GPCRs, Class A Rhodopsin-like—AGTR2—dilated cardiomyopathy	0.000234	0.00178	CbGpPWpGaD
Doxazosin—ADRA1A—GPCRs, Class A Rhodopsin-like—ADRB1—dilated cardiomyopathy	0.000227	0.00172	CbGpPWpGaD
Doxazosin—ADRA1B—Class A/1 (Rhodopsin-like receptors)—CXCR3—dilated cardiomyopathy	0.000226	0.00171	CbGpPWpGaD
Doxazosin—ADRA2A—Hemostasis—ACTN2—dilated cardiomyopathy	0.000225	0.00171	CbGpPWpGaD
Doxazosin—ADRA1D—Class A/1 (Rhodopsin-like receptors)—AGTR1—dilated cardiomyopathy	0.000225	0.00171	CbGpPWpGaD
Doxazosin—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—AGTR1—dilated cardiomyopathy	0.000224	0.0017	CbGpPWpGaD
Doxazosin—ADRA1D—GPCR ligand binding—AGTR2—dilated cardiomyopathy	0.000223	0.00169	CbGpPWpGaD
Doxazosin—ADRA1D—GPCR ligand binding—CXCL2—dilated cardiomyopathy	0.000223	0.00169	CbGpPWpGaD
Doxazosin—ADRA1B—LPA receptor mediated events—EGFR—dilated cardiomyopathy	0.000223	0.00169	CbGpPWpGaD
Doxazosin—CYP2C19—Metabolism of lipids and lipoproteins—TAZ—dilated cardiomyopathy	0.000221	0.00168	CbGpPWpGaD
Doxazosin—ADRA1B—Class A/1 (Rhodopsin-like receptors)—ADRB1—dilated cardiomyopathy	0.000219	0.00166	CbGpPWpGaD
Doxazosin—ADRA1B—GPCRs, Class A Rhodopsin-like—AGTR1—dilated cardiomyopathy	0.000218	0.00166	CbGpPWpGaD
Doxazosin—ADRA2A—GPCRs, Class A Rhodopsin-like—CXCR3—dilated cardiomyopathy	0.000217	0.00165	CbGpPWpGaD
Doxazosin—ADRA1A—Class A/1 (Rhodopsin-like receptors)—CXCL2—dilated cardiomyopathy	0.000216	0.00164	CbGpPWpGaD
Doxazosin—ADRA1A—Class A/1 (Rhodopsin-like receptors)—AGTR2—dilated cardiomyopathy	0.000216	0.00164	CbGpPWpGaD
Doxazosin—ADRA1D—Gastrin-CREB signalling pathway via PKC and MAPK—AGT—dilated cardiomyopathy	0.000214	0.00162	CbGpPWpGaD
Doxazosin—ADRA1D—Class A/1 (Rhodopsin-like receptors)—ADRB2—dilated cardiomyopathy	0.000213	0.00162	CbGpPWpGaD
Doxazosin—ADRA2A—GPCRs, Class A Rhodopsin-like—ADRB1—dilated cardiomyopathy	0.000211	0.0016	CbGpPWpGaD
Doxazosin—ADRA1D—GPCR ligand binding—CXCR3—dilated cardiomyopathy	0.000207	0.00157	CbGpPWpGaD
Doxazosin—ADRA1B—GPCRs, Class A Rhodopsin-like—ADRB2—dilated cardiomyopathy	0.000207	0.00157	CbGpPWpGaD
Doxazosin—ADRA1D—GPCR ligand binding—ADRB1—dilated cardiomyopathy	0.000201	0.00152	CbGpPWpGaD
Doxazosin—ADRA1A—Class A/1 (Rhodopsin-like receptors)—CXCR3—dilated cardiomyopathy	0.0002	0.00152	CbGpPWpGaD
Doxazosin—ADRA2A—Class A/1 (Rhodopsin-like receptors)—AGTR2—dilated cardiomyopathy	0.0002	0.00152	CbGpPWpGaD
Doxazosin—ADRA2A—Class A/1 (Rhodopsin-like receptors)—CXCL2—dilated cardiomyopathy	0.0002	0.00152	CbGpPWpGaD
Doxazosin—ADRA1B—G alpha (q) signalling events—AGT—dilated cardiomyopathy	0.000198	0.00151	CbGpPWpGaD
Doxazosin—ADRA1A—Class A/1 (Rhodopsin-like receptors)—ADRB1—dilated cardiomyopathy	0.000194	0.00148	CbGpPWpGaD
Doxazosin—ADRA1A—GPCRs, Class A Rhodopsin-like—AGTR1—dilated cardiomyopathy	0.000194	0.00147	CbGpPWpGaD
Doxazosin—ADRA2A—Hemostasis—VCL—dilated cardiomyopathy	0.000191	0.00145	CbGpPWpGaD
Doxazosin—ADRA1B—Class A/1 (Rhodopsin-like receptors)—AGTR1—dilated cardiomyopathy	0.000187	0.00142	CbGpPWpGaD
Doxazosin—ADRA2A—Class A/1 (Rhodopsin-like receptors)—CXCR3—dilated cardiomyopathy	0.000186	0.00142	CbGpPWpGaD
Doxazosin—ADRA1B—GPCR ligand binding—CXCL2—dilated cardiomyopathy	0.000185	0.0014	CbGpPWpGaD
Doxazosin—ADRA1B—GPCR ligand binding—AGTR2—dilated cardiomyopathy	0.000185	0.0014	CbGpPWpGaD
Doxazosin—ADRA1A—GPCRs, Class A Rhodopsin-like—ADRB2—dilated cardiomyopathy	0.000184	0.00139	CbGpPWpGaD
Doxazosin—ADRA2A—Class A/1 (Rhodopsin-like receptors)—ADRB1—dilated cardiomyopathy	0.00018	0.00137	CbGpPWpGaD
Doxazosin—ADRA2A—GPCRs, Class A Rhodopsin-like—AGTR1—dilated cardiomyopathy	0.00018	0.00137	CbGpPWpGaD
Doxazosin—ADRA1B—Gastrin-CREB signalling pathway via PKC and MAPK—AGT—dilated cardiomyopathy	0.000177	0.00135	CbGpPWpGaD
Doxazosin—ADRA1B—Class A/1 (Rhodopsin-like receptors)—ADRB2—dilated cardiomyopathy	0.000177	0.00135	CbGpPWpGaD
Doxazosin—ADRA1A—G alpha (q) signalling events—AGT—dilated cardiomyopathy	0.000176	0.00134	CbGpPWpGaD
Doxazosin—KCNH2—SIDS Susceptibility Pathways—TNF—dilated cardiomyopathy	0.000174	0.00132	CbGpPWpGaD
Doxazosin—ADRA1B—GPCR ligand binding—CXCR3—dilated cardiomyopathy	0.000172	0.00131	CbGpPWpGaD
Doxazosin—ADRA1D—GPCR ligand binding—AGTR1—dilated cardiomyopathy	0.000171	0.0013	CbGpPWpGaD
Doxazosin—ADRA2A—GPCRs, Class A Rhodopsin-like—ADRB2—dilated cardiomyopathy	0.000171	0.0013	CbGpPWpGaD
Doxazosin—KCNH2—Neuronal System—RAF1—dilated cardiomyopathy	0.000167	0.00127	CbGpPWpGaD
Doxazosin—ADRA1B—GPCR ligand binding—ADRB1—dilated cardiomyopathy	0.000166	0.00126	CbGpPWpGaD
Doxazosin—ADRA1A—Class A/1 (Rhodopsin-like receptors)—AGTR1—dilated cardiomyopathy	0.000166	0.00126	CbGpPWpGaD
Doxazosin—ADRA1A—GPCR ligand binding—AGTR2—dilated cardiomyopathy	0.000164	0.00125	CbGpPWpGaD
Doxazosin—ADRA1A—GPCR ligand binding—CXCL2—dilated cardiomyopathy	0.000164	0.00125	CbGpPWpGaD
Doxazosin—ADRA1D—GPCR ligand binding—ADRB2—dilated cardiomyopathy	0.000163	0.00123	CbGpPWpGaD
Doxazosin—ADRA2A—Platelet activation, signaling and aggregation—CD36—dilated cardiomyopathy	0.000159	0.00121	CbGpPWpGaD
Doxazosin—ADRA1D—Class A/1 (Rhodopsin-like receptors)—AGT—dilated cardiomyopathy	0.000158	0.0012	CbGpPWpGaD
Doxazosin—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—AGT—dilated cardiomyopathy	0.000158	0.0012	CbGpPWpGaD
Doxazosin—ADRA1A—Class A/1 (Rhodopsin-like receptors)—ADRB2—dilated cardiomyopathy	0.000157	0.0012	CbGpPWpGaD
Doxazosin—ABCB1—Transmembrane transport of small molecules—RYR2—dilated cardiomyopathy	0.000155	0.00118	CbGpPWpGaD
Doxazosin—ADRA2A—Class A/1 (Rhodopsin-like receptors)—AGTR1—dilated cardiomyopathy	0.000154	0.00117	CbGpPWpGaD
Doxazosin—ADRA1A—GPCR ligand binding—CXCR3—dilated cardiomyopathy	0.000153	0.00116	CbGpPWpGaD
Doxazosin—ADRA2A—GPCR ligand binding—CXCL2—dilated cardiomyopathy	0.000153	0.00116	CbGpPWpGaD
Doxazosin—ADRA2A—GPCR ligand binding—AGTR2—dilated cardiomyopathy	0.000153	0.00116	CbGpPWpGaD
Doxazosin—ABCB1—Transmembrane transport of small molecules—SLC22A5—dilated cardiomyopathy	0.000151	0.00115	CbGpPWpGaD
Doxazosin—ABCB1—Transmembrane transport of small molecules—PLN—dilated cardiomyopathy	0.000151	0.00115	CbGpPWpGaD
Doxazosin—ADRA2A—Platelet activation, signaling and aggregation—RAC1—dilated cardiomyopathy	0.00015	0.00114	CbGpPWpGaD
Doxazosin—ADRA1D—Gastrin-CREB signalling pathway via PKC and MAPK—RAF1—dilated cardiomyopathy	0.000148	0.00113	CbGpPWpGaD
Doxazosin—ADRA1A—GPCR ligand binding—ADRB1—dilated cardiomyopathy	0.000148	0.00112	CbGpPWpGaD
Doxazosin—ADRA2A—Metabolism—ANKRD1—dilated cardiomyopathy	0.000148	0.00112	CbGpPWpGaD
Doxazosin—ADRA2A—Class A/1 (Rhodopsin-like receptors)—ADRB2—dilated cardiomyopathy	0.000146	0.00111	CbGpPWpGaD
Doxazosin—ADRA1B—GPCR ligand binding—AGTR1—dilated cardiomyopathy	0.000142	0.00108	CbGpPWpGaD
Doxazosin—ADRA2A—GPCR ligand binding—CXCR3—dilated cardiomyopathy	0.000142	0.00108	CbGpPWpGaD
Doxazosin—ABCB1—Transmembrane transport of small molecules—ABCC9—dilated cardiomyopathy	0.000141	0.00107	CbGpPWpGaD
Doxazosin—ADRA2A—Metabolism—TAZ—dilated cardiomyopathy	0.000139	0.00106	CbGpPWpGaD
Doxazosin—ADRA2A—GPCR ligand binding—ADRB1—dilated cardiomyopathy	0.000137	0.00104	CbGpPWpGaD
Doxazosin—ADRA2A—G alpha (i) signalling events—AGT—dilated cardiomyopathy	0.000136	0.00104	CbGpPWpGaD
Doxazosin—ADRA1B—GPCR ligand binding—ADRB2—dilated cardiomyopathy	0.000135	0.00102	CbGpPWpGaD
Doxazosin—ADRA1B—Class A/1 (Rhodopsin-like receptors)—AGT—dilated cardiomyopathy	0.000131	0.000998	CbGpPWpGaD
Doxazosin—ADRA1A—GPCR ligand binding—AGTR1—dilated cardiomyopathy	0.000126	0.000959	CbGpPWpGaD
Doxazosin—ADRA1D—GPCR downstream signaling—AGTR2—dilated cardiomyopathy	0.000126	0.000956	CbGpPWpGaD
Doxazosin—ADRA1D—GPCR downstream signaling—CXCL2—dilated cardiomyopathy	0.000126	0.000956	CbGpPWpGaD
Doxazosin—ADRA2A—Metabolism—SDHA—dilated cardiomyopathy	0.000126	0.000955	CbGpPWpGaD
Doxazosin—ABCB1—Integrated Pancreatic Cancer Pathway—FASLG—dilated cardiomyopathy	0.000123	0.000936	CbGpPWpGaD
Doxazosin—ADRA1B—Gastrin-CREB signalling pathway via PKC and MAPK—RAF1—dilated cardiomyopathy	0.000123	0.000935	CbGpPWpGaD
Doxazosin—ADRA1D—GPCR ligand binding—AGT—dilated cardiomyopathy	0.000121	0.000916	CbGpPWpGaD
Doxazosin—ADRA1A—GPCR ligand binding—ADRB2—dilated cardiomyopathy	0.00012	0.00091	CbGpPWpGaD
Doxazosin—ABCB1—Integrated Pancreatic Cancer Pathway—FAS—dilated cardiomyopathy	0.000119	0.000903	CbGpPWpGaD
Doxazosin—ADRA2A—GPCR ligand binding—AGTR1—dilated cardiomyopathy	0.000117	0.000891	CbGpPWpGaD
Doxazosin—ADRA1D—GPCR downstream signaling—CXCR3—dilated cardiomyopathy	0.000117	0.000889	CbGpPWpGaD
Doxazosin—ADRA1A—Class A/1 (Rhodopsin-like receptors)—AGT—dilated cardiomyopathy	0.000117	0.000887	CbGpPWpGaD
Doxazosin—ABCB1—Integrated Pancreatic Cancer Pathway—RAC1—dilated cardiomyopathy	0.000116	0.000885	CbGpPWpGaD
Doxazosin—ADRA1D—Signaling by GPCR—CXCL2—dilated cardiomyopathy	0.000114	0.000868	CbGpPWpGaD
Doxazosin—ADRA1D—Signaling by GPCR—AGTR2—dilated cardiomyopathy	0.000114	0.000868	CbGpPWpGaD
Doxazosin—ADRA1D—GPCR downstream signaling—ADRB1—dilated cardiomyopathy	0.000113	0.000861	CbGpPWpGaD
Doxazosin—ADRA2A—GPCR ligand binding—ADRB2—dilated cardiomyopathy	0.000111	0.000846	CbGpPWpGaD
Doxazosin—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—RAF1—dilated cardiomyopathy	0.000109	0.000831	CbGpPWpGaD
Doxazosin—ADRA2A—Class A/1 (Rhodopsin-like receptors)—AGT—dilated cardiomyopathy	0.000108	0.000824	CbGpPWpGaD
Doxazosin—ADRA1D—Signaling by GPCR—CXCR3—dilated cardiomyopathy	0.000106	0.000807	CbGpPWpGaD
Doxazosin—CYP2C19—Metabolism—ANKRD1—dilated cardiomyopathy	0.000105	0.000795	CbGpPWpGaD
Doxazosin—ADRA1B—GPCR downstream signaling—AGTR2—dilated cardiomyopathy	0.000104	0.000794	CbGpPWpGaD
Doxazosin—ADRA1B—GPCR downstream signaling—CXCL2—dilated cardiomyopathy	0.000104	0.000794	CbGpPWpGaD
Doxazosin—ADRA1D—Signaling by GPCR—ADRB1—dilated cardiomyopathy	0.000103	0.000782	CbGpPWpGaD
Doxazosin—ABCB1—Allograft Rejection—TNF—dilated cardiomyopathy	0.000102	0.000777	CbGpPWpGaD
Doxazosin—ABCB1—Metabolism—ANKRD1—dilated cardiomyopathy	0.000102	0.000776	CbGpPWpGaD
Doxazosin—ADRA1D—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—dilated cardiomyopathy	0.000102	0.000773	CbGpPWpGaD
Doxazosin—ADRA1B—GPCR ligand binding—AGT—dilated cardiomyopathy	0.0001	0.00076	CbGpPWpGaD
Doxazosin—ADRA2A—Platelet activation, signaling and aggregation—RAF1—dilated cardiomyopathy	9.94e-05	0.000755	CbGpPWpGaD
Doxazosin—CYP2C19—Metabolism—TAZ—dilated cardiomyopathy	9.84e-05	0.000748	CbGpPWpGaD
Doxazosin—ADRA1B—GPCR downstream signaling—CXCR3—dilated cardiomyopathy	9.71e-05	0.000738	CbGpPWpGaD
Doxazosin—ADRA1D—GPCR downstream signaling—AGTR1—dilated cardiomyopathy	9.68e-05	0.000735	CbGpPWpGaD
Doxazosin—CYP2D6—Metabolism—ANKRD1—dilated cardiomyopathy	9.63e-05	0.000732	CbGpPWpGaD
Doxazosin—ADRA2A—Hemostasis—ITGB1—dilated cardiomyopathy	9.61e-05	0.00073	CbGpPWpGaD
Doxazosin—ABCB1—Metabolism—TAZ—dilated cardiomyopathy	9.61e-05	0.00073	CbGpPWpGaD
Doxazosin—ADRA1B—Signaling by GPCR—CXCL2—dilated cardiomyopathy	9.49e-05	0.000721	CbGpPWpGaD
Doxazosin—ADRA1B—Signaling by GPCR—AGTR2—dilated cardiomyopathy	9.49e-05	0.000721	CbGpPWpGaD
Doxazosin—ADRA1B—GPCR downstream signaling—ADRB1—dilated cardiomyopathy	9.41e-05	0.000715	CbGpPWpGaD
Doxazosin—ADRA1A—GPCR downstream signaling—CXCL2—dilated cardiomyopathy	9.28e-05	0.000705	CbGpPWpGaD
Doxazosin—ADRA1A—GPCR downstream signaling—AGTR2—dilated cardiomyopathy	9.28e-05	0.000705	CbGpPWpGaD
Doxazosin—ADRA1D—GPCR downstream signaling—ADRB2—dilated cardiomyopathy	9.18e-05	0.000698	CbGpPWpGaD
Doxazosin—CYP2D6—Metabolism—TAZ—dilated cardiomyopathy	9.05e-05	0.000688	CbGpPWpGaD
Doxazosin—CYP2C19—Metabolism—SDHA—dilated cardiomyopathy	8.9e-05	0.000676	CbGpPWpGaD
Doxazosin—ADRA1A—GPCR ligand binding—AGT—dilated cardiomyopathy	8.89e-05	0.000675	CbGpPWpGaD
Doxazosin—ADRA1B—Signaling by GPCR—CXCR3—dilated cardiomyopathy	8.82e-05	0.00067	CbGpPWpGaD
Doxazosin—ADRA1D—Signaling by GPCR—AGTR1—dilated cardiomyopathy	8.79e-05	0.000668	CbGpPWpGaD
Doxazosin—ABCB1—Metabolism—SDHA—dilated cardiomyopathy	8.69e-05	0.00066	CbGpPWpGaD
Doxazosin—ADRA1A—GPCR downstream signaling—CXCR3—dilated cardiomyopathy	8.63e-05	0.000655	CbGpPWpGaD
Doxazosin—ADRA2A—GPCR downstream signaling—CXCL2—dilated cardiomyopathy	8.62e-05	0.000655	CbGpPWpGaD
Doxazosin—ADRA2A—GPCR downstream signaling—AGTR2—dilated cardiomyopathy	8.62e-05	0.000655	CbGpPWpGaD
Doxazosin—ADRA1B—Signaling by GPCR—ADRB1—dilated cardiomyopathy	8.54e-05	0.000649	CbGpPWpGaD
Doxazosin—ADRA1B—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—dilated cardiomyopathy	8.44e-05	0.000641	CbGpPWpGaD
Doxazosin—ADRA1A—Signaling by GPCR—CXCL2—dilated cardiomyopathy	8.43e-05	0.00064	CbGpPWpGaD
Doxazosin—ADRA1A—Signaling by GPCR—AGTR2—dilated cardiomyopathy	8.43e-05	0.00064	CbGpPWpGaD
Doxazosin—ADRA1A—GPCR downstream signaling—ADRB1—dilated cardiomyopathy	8.36e-05	0.000635	CbGpPWpGaD
Doxazosin—ADRA1D—Signaling by GPCR—ADRB2—dilated cardiomyopathy	8.34e-05	0.000634	CbGpPWpGaD
Doxazosin—ADRA2A—GPCR ligand binding—AGT—dilated cardiomyopathy	8.26e-05	0.000627	CbGpPWpGaD
Doxazosin—ADRA2A—Hemostasis—CD36—dilated cardiomyopathy	8.2e-05	0.000623	CbGpPWpGaD
Doxazosin—CYP2D6—Metabolism—SDHA—dilated cardiomyopathy	8.19e-05	0.000622	CbGpPWpGaD
Doxazosin—ADRA1B—GPCR downstream signaling—AGTR1—dilated cardiomyopathy	8.03e-05	0.00061	CbGpPWpGaD
Doxazosin—ADRA2A—GPCR downstream signaling—CXCR3—dilated cardiomyopathy	8.02e-05	0.000609	CbGpPWpGaD
Doxazosin—ADRA1A—Signaling by GPCR—CXCR3—dilated cardiomyopathy	7.83e-05	0.000595	CbGpPWpGaD
Doxazosin—ADRA2A—Signaling by GPCR—CXCL2—dilated cardiomyopathy	7.83e-05	0.000595	CbGpPWpGaD
Doxazosin—ADRA2A—Signaling by GPCR—AGTR2—dilated cardiomyopathy	7.83e-05	0.000595	CbGpPWpGaD
Doxazosin—ADRA2A—GPCR downstream signaling—ADRB1—dilated cardiomyopathy	7.76e-05	0.00059	CbGpPWpGaD
Doxazosin—ADRA2A—Hemostasis—RAC1—dilated cardiomyopathy	7.73e-05	0.000587	CbGpPWpGaD
Doxazosin—ABCB1—Integrated Pancreatic Cancer Pathway—RAF1—dilated cardiomyopathy	7.72e-05	0.000587	CbGpPWpGaD
Doxazosin—ADRA1B—GPCR downstream signaling—ADRB2—dilated cardiomyopathy	7.62e-05	0.000579	CbGpPWpGaD
Doxazosin—ADRA1D—Signaling Pathways—PSEN2—dilated cardiomyopathy	7.61e-05	0.000578	CbGpPWpGaD
Doxazosin—ADRA1A—Signaling by GPCR—ADRB1—dilated cardiomyopathy	7.59e-05	0.000576	CbGpPWpGaD
Doxazosin—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—dilated cardiomyopathy	7.5e-05	0.00057	CbGpPWpGaD
Doxazosin—ADRA1B—Signaling by GPCR—AGTR1—dilated cardiomyopathy	7.3e-05	0.000554	CbGpPWpGaD
Doxazosin—ADRA2A—Signaling by GPCR—CXCR3—dilated cardiomyopathy	7.28e-05	0.000553	CbGpPWpGaD
Doxazosin—ADRA1A—GPCR downstream signaling—AGTR1—dilated cardiomyopathy	7.14e-05	0.000542	CbGpPWpGaD
Doxazosin—ADRA1D—GPCR downstream signaling—RAC1—dilated cardiomyopathy	7.13e-05	0.000542	CbGpPWpGaD
Doxazosin—ADRA2A—Signaling by GPCR—ADRB1—dilated cardiomyopathy	7.05e-05	0.000536	CbGpPWpGaD
Doxazosin—ADRA1B—Signaling by GPCR—ADRB2—dilated cardiomyopathy	6.92e-05	0.000526	CbGpPWpGaD
Doxazosin—ADRA1D—GPCR downstream signaling—AGT—dilated cardiomyopathy	6.81e-05	0.000517	CbGpPWpGaD
Doxazosin—ADRA1A—GPCR downstream signaling—ADRB2—dilated cardiomyopathy	6.77e-05	0.000514	CbGpPWpGaD
Doxazosin—ADRA1D—Signaling Pathways—AGTR2—dilated cardiomyopathy	6.75e-05	0.000513	CbGpPWpGaD
Doxazosin—ADRA1D—Signaling Pathways—CXCL2—dilated cardiomyopathy	6.75e-05	0.000513	CbGpPWpGaD
Doxazosin—ADRA2A—GPCR downstream signaling—AGTR1—dilated cardiomyopathy	6.63e-05	0.000504	CbGpPWpGaD
Doxazosin—ADRA1A—Signaling by GPCR—AGTR1—dilated cardiomyopathy	6.48e-05	0.000492	CbGpPWpGaD
Doxazosin—ADRA1D—Signaling by GPCR—RAC1—dilated cardiomyopathy	6.47e-05	0.000492	CbGpPWpGaD
Doxazosin—ADRA1B—Signaling Pathways—PSEN2—dilated cardiomyopathy	6.31e-05	0.00048	CbGpPWpGaD
Doxazosin—ADRA2A—GPCR downstream signaling—ADRB2—dilated cardiomyopathy	6.29e-05	0.000478	CbGpPWpGaD
Doxazosin—ADRA1D—Signaling Pathways—CXCR3—dilated cardiomyopathy	6.28e-05	0.000477	CbGpPWpGaD
Doxazosin—ADRA1D—Signaling by GPCR—AGT—dilated cardiomyopathy	6.19e-05	0.00047	CbGpPWpGaD
Doxazosin—ADRA1A—Signaling by GPCR—ADRB2—dilated cardiomyopathy	6.15e-05	0.000467	CbGpPWpGaD
Doxazosin—ADRA1D—Signaling Pathways—ADRB1—dilated cardiomyopathy	6.08e-05	0.000462	CbGpPWpGaD
Doxazosin—ADRA2A—Signaling by GPCR—AGTR1—dilated cardiomyopathy	6.02e-05	0.000457	CbGpPWpGaD
Doxazosin—ADRA1B—GPCR downstream signaling—RAC1—dilated cardiomyopathy	5.92e-05	0.00045	CbGpPWpGaD
Doxazosin—ADRA2A—Signaling by GPCR—ADRB2—dilated cardiomyopathy	5.71e-05	0.000434	CbGpPWpGaD
Doxazosin—ADRA1B—GPCR downstream signaling—AGT—dilated cardiomyopathy	5.65e-05	0.00043	CbGpPWpGaD
Doxazosin—ADRA1A—Signaling Pathways—PSEN2—dilated cardiomyopathy	5.61e-05	0.000426	CbGpPWpGaD
Doxazosin—ADRA1B—Signaling Pathways—AGTR2—dilated cardiomyopathy	5.6e-05	0.000426	CbGpPWpGaD
Doxazosin—ADRA1B—Signaling Pathways—CXCL2—dilated cardiomyopathy	5.6e-05	0.000426	CbGpPWpGaD
Doxazosin—CYP2C19—Metabolism of lipids and lipoproteins—GPX1—dilated cardiomyopathy	5.43e-05	0.000413	CbGpPWpGaD
Doxazosin—ADRA1B—Signaling by GPCR—RAC1—dilated cardiomyopathy	5.37e-05	0.000408	CbGpPWpGaD
Doxazosin—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—dilated cardiomyopathy	5.3e-05	0.000402	CbGpPWpGaD
Doxazosin—CYP2C19—Metabolism of lipids and lipoproteins—CD36—dilated cardiomyopathy	5.29e-05	0.000402	CbGpPWpGaD
Doxazosin—ADRA1A—GPCR downstream signaling—RAC1—dilated cardiomyopathy	5.26e-05	0.000399	CbGpPWpGaD
Doxazosin—ADRA1B—Signaling Pathways—CXCR3—dilated cardiomyopathy	5.21e-05	0.000396	CbGpPWpGaD
Doxazosin—ADRA2A—Signaling Pathways—PSEN2—dilated cardiomyopathy	5.21e-05	0.000396	CbGpPWpGaD
Doxazosin—ADRA1D—Signaling Pathways—AGTR1—dilated cardiomyopathy	5.19e-05	0.000394	CbGpPWpGaD
Doxazosin—ADRA1B—Signaling by GPCR—AGT—dilated cardiomyopathy	5.13e-05	0.00039	CbGpPWpGaD
Doxazosin—ADRA2A—Hemostasis—RAF1—dilated cardiomyopathy	5.12e-05	0.000389	CbGpPWpGaD
Doxazosin—ADRA1B—Signaling Pathways—ADRB1—dilated cardiomyopathy	5.05e-05	0.000383	CbGpPWpGaD
Doxazosin—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—dilated cardiomyopathy	5.04e-05	0.000383	CbGpPWpGaD
Doxazosin—ADRA1A—GPCR downstream signaling—AGT—dilated cardiomyopathy	5.02e-05	0.000382	CbGpPWpGaD
Doxazosin—ADRA1A—Signaling Pathways—AGTR2—dilated cardiomyopathy	4.98e-05	0.000378	CbGpPWpGaD
Doxazosin—ADRA1A—Signaling Pathways—CXCL2—dilated cardiomyopathy	4.98e-05	0.000378	CbGpPWpGaD
Doxazosin—ADRA1D—Signaling Pathways—ADRB2—dilated cardiomyopathy	4.93e-05	0.000374	CbGpPWpGaD
Doxazosin—ADRA2A—GPCR downstream signaling—RAC1—dilated cardiomyopathy	4.88e-05	0.000371	CbGpPWpGaD
Doxazosin—ADRA1A—Signaling by GPCR—RAC1—dilated cardiomyopathy	4.77e-05	0.000363	CbGpPWpGaD
Doxazosin—CYP2C19—Metabolism of lipids and lipoproteins—AGT—dilated cardiomyopathy	4.76e-05	0.000362	CbGpPWpGaD
Doxazosin—ADRA2A—GPCR downstream signaling—AGT—dilated cardiomyopathy	4.67e-05	0.000354	CbGpPWpGaD
Doxazosin—ADRA1A—Signaling Pathways—CXCR3—dilated cardiomyopathy	4.63e-05	0.000352	CbGpPWpGaD
Doxazosin—ADRA2A—Signaling Pathways—AGTR2—dilated cardiomyopathy	4.63e-05	0.000351	CbGpPWpGaD
Doxazosin—ADRA2A—Signaling Pathways—CXCL2—dilated cardiomyopathy	4.63e-05	0.000351	CbGpPWpGaD
Doxazosin—ADRA1A—Signaling by GPCR—AGT—dilated cardiomyopathy	4.56e-05	0.000346	CbGpPWpGaD
Doxazosin—ADRA1A—Signaling Pathways—ADRB1—dilated cardiomyopathy	4.48e-05	0.000341	CbGpPWpGaD
Doxazosin—ADRA2A—Signaling by GPCR—RAC1—dilated cardiomyopathy	4.43e-05	0.000337	CbGpPWpGaD
Doxazosin—ADRA1B—Signaling Pathways—AGTR1—dilated cardiomyopathy	4.31e-05	0.000327	CbGpPWpGaD
Doxazosin—ADRA2A—Signaling Pathways—CXCR3—dilated cardiomyopathy	4.3e-05	0.000327	CbGpPWpGaD
Doxazosin—ADRA1D—Signaling by GPCR—RAF1—dilated cardiomyopathy	4.29e-05	0.000326	CbGpPWpGaD
Doxazosin—ADRA2A—Signaling by GPCR—AGT—dilated cardiomyopathy	4.24e-05	0.000322	CbGpPWpGaD
Doxazosin—ADRA1D—Signaling Pathways—RPS6KB1—dilated cardiomyopathy	4.23e-05	0.000322	CbGpPWpGaD
Doxazosin—ADRA2A—Signaling Pathways—ADRB1—dilated cardiomyopathy	4.16e-05	0.000316	CbGpPWpGaD
Doxazosin—ADRA1B—Signaling Pathways—ADRB2—dilated cardiomyopathy	4.09e-05	0.000311	CbGpPWpGaD
Doxazosin—ADRA1A—Signaling Pathways—AGTR1—dilated cardiomyopathy	3.83e-05	0.000291	CbGpPWpGaD
Doxazosin—ADRA1D—Signaling Pathways—RAC1—dilated cardiomyopathy	3.82e-05	0.000291	CbGpPWpGaD
Doxazosin—ADRA1D—Signaling Pathways—AGT—dilated cardiomyopathy	3.65e-05	0.000278	CbGpPWpGaD
Doxazosin—ADRA1A—Signaling Pathways—ADRB2—dilated cardiomyopathy	3.63e-05	0.000276	CbGpPWpGaD
Doxazosin—ADRA1B—Signaling by GPCR—RAF1—dilated cardiomyopathy	3.56e-05	0.000271	CbGpPWpGaD
Doxazosin—ADRA2A—Signaling Pathways—AGTR1—dilated cardiomyopathy	3.56e-05	0.00027	CbGpPWpGaD
Doxazosin—ADRA1B—Signaling Pathways—RPS6KB1—dilated cardiomyopathy	3.51e-05	0.000267	CbGpPWpGaD
Doxazosin—ADRA2A—Metabolism—GPX1—dilated cardiomyopathy	3.41e-05	0.000259	CbGpPWpGaD
Doxazosin—ADRA2A—Signaling Pathways—ADRB2—dilated cardiomyopathy	3.37e-05	0.000256	CbGpPWpGaD
Doxazosin—ADRA2A—Metabolism—CD36—dilated cardiomyopathy	3.32e-05	0.000253	CbGpPWpGaD
Doxazosin—ADRA1B—Signaling Pathways—RAC1—dilated cardiomyopathy	3.17e-05	0.000241	CbGpPWpGaD
Doxazosin—ADRA1A—Signaling by GPCR—RAF1—dilated cardiomyopathy	3.16e-05	0.00024	CbGpPWpGaD
Doxazosin—ADRA1A—Signaling Pathways—RPS6KB1—dilated cardiomyopathy	3.12e-05	0.000237	CbGpPWpGaD
Doxazosin—ABCB1—Transmembrane transport of small molecules—RAF1—dilated cardiomyopathy	3.07e-05	0.000233	CbGpPWpGaD
Doxazosin—ADRA1B—Signaling Pathways—AGT—dilated cardiomyopathy	3.03e-05	0.00023	CbGpPWpGaD
Doxazosin—ADRA2A—Metabolism—AGT—dilated cardiomyopathy	2.99e-05	0.000227	CbGpPWpGaD
Doxazosin—ADRA1D—Signaling by GPCR—EGFR—dilated cardiomyopathy	2.94e-05	0.000224	CbGpPWpGaD
Doxazosin—ADRA2A—Signaling by GPCR—RAF1—dilated cardiomyopathy	2.94e-05	0.000223	CbGpPWpGaD
Doxazosin—ADRA2A—Signaling Pathways—RPS6KB1—dilated cardiomyopathy	2.9e-05	0.00022	CbGpPWpGaD
Doxazosin—ADRA1A—Signaling Pathways—RAC1—dilated cardiomyopathy	2.82e-05	0.000214	CbGpPWpGaD
Doxazosin—ADRA1A—Signaling Pathways—AGT—dilated cardiomyopathy	2.69e-05	0.000205	CbGpPWpGaD
Doxazosin—ADRA2A—Signaling Pathways—RAC1—dilated cardiomyopathy	2.62e-05	0.000199	CbGpPWpGaD
Doxazosin—ADRA1D—Signaling Pathways—RAF1—dilated cardiomyopathy	2.54e-05	0.000193	CbGpPWpGaD
Doxazosin—ADRA2A—Signaling Pathways—AGT—dilated cardiomyopathy	2.5e-05	0.00019	CbGpPWpGaD
Doxazosin—ADRA1B—Signaling by GPCR—EGFR—dilated cardiomyopathy	2.44e-05	0.000186	CbGpPWpGaD
Doxazosin—CYP2C19—Metabolism—GPX1—dilated cardiomyopathy	2.42e-05	0.000184	CbGpPWpGaD
Doxazosin—ABCB1—Metabolism—GPX1—dilated cardiomyopathy	2.36e-05	0.000179	CbGpPWpGaD
Doxazosin—CYP2C19—Metabolism—CD36—dilated cardiomyopathy	2.36e-05	0.000179	CbGpPWpGaD
Doxazosin—ABCB1—Metabolism—CD36—dilated cardiomyopathy	2.3e-05	0.000175	CbGpPWpGaD
Doxazosin—CYP2D6—Metabolism—GPX1—dilated cardiomyopathy	2.22e-05	0.000169	CbGpPWpGaD
Doxazosin—ADRA1A—Signaling by GPCR—EGFR—dilated cardiomyopathy	2.17e-05	0.000165	CbGpPWpGaD
Doxazosin—CYP2D6—Metabolism—CD36—dilated cardiomyopathy	2.17e-05	0.000165	CbGpPWpGaD
Doxazosin—CYP2C19—Metabolism—AGT—dilated cardiomyopathy	2.12e-05	0.000161	CbGpPWpGaD
Doxazosin—ADRA1B—Signaling Pathways—RAF1—dilated cardiomyopathy	2.1e-05	0.00016	CbGpPWpGaD
Doxazosin—ABCB1—Metabolism—AGT—dilated cardiomyopathy	2.07e-05	0.000157	CbGpPWpGaD
Doxazosin—ADRA2A—Signaling by GPCR—EGFR—dilated cardiomyopathy	2.02e-05	0.000153	CbGpPWpGaD
Doxazosin—CYP2D6—Metabolism—AGT—dilated cardiomyopathy	1.95e-05	0.000148	CbGpPWpGaD
Doxazosin—ADRA1A—Signaling Pathways—RAF1—dilated cardiomyopathy	1.87e-05	0.000142	CbGpPWpGaD
Doxazosin—ADRA1D—Signaling Pathways—EGFR—dilated cardiomyopathy	1.74e-05	0.000132	CbGpPWpGaD
Doxazosin—ADRA2A—Signaling Pathways—RAF1—dilated cardiomyopathy	1.74e-05	0.000132	CbGpPWpGaD
Doxazosin—ADRA1B—Signaling Pathways—EGFR—dilated cardiomyopathy	1.44e-05	0.00011	CbGpPWpGaD
Doxazosin—ADRA1A—Signaling Pathways—EGFR—dilated cardiomyopathy	1.28e-05	9.74e-05	CbGpPWpGaD
Doxazosin—ADRA2A—Signaling Pathways—EGFR—dilated cardiomyopathy	1.19e-05	9.05e-05	CbGpPWpGaD
